You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同和药业(300636.SZ)取得一项发明专利证书
格隆汇 07-02 21:14

格隆汇 7 月 2日丨同和药业(300636.SZ)公布,公司于近日收到中华人民共和国国家知识产权局颁发的发明专利证书,涉一种7-羟基-1-四氢萘酮的制备方法。

该发明的7-羟基-1-四氢萘酮(CAS:22009-38-7)是抗丙肝药物维帕他韦的中间体,也可作为其他药物的中间体。

该发明提供一种新颖的7-羟基-1-四氢萘酮的制备方法,该方法通过一锅法即可制备得到目标产物,步骤简洁、成本低、安全可靠且环境友好,得到的产品收率高、质量优异,该方法非常适合于工业化生产。

上述发明专利的取得不会对公司近期生产经营产生重大影响,但有利于发挥公司自主知识产权技术优势,完善知识产权保护体系,从而增强公司核心竞争力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account